article thumbnail

IGC Completes Cohort 2 of its Phase 1 THC-Based Clinical Trial on Alzheimer’s Patients

Cannabis Law Report

IGC”) (NYSE American: IGC) announces today that it has completed Cohort 2 of its Phase 1 clinical trial on IGC’s tetrahydrocannabinol (“THC”)-based investigational new drug, IGC-AD1, intended to alleviate the symptoms of individuals suffering from Alzheimer’s disease. This Phase 1 trial is currently testing IGC-AD1 for safety.

article thumbnail

Cannabinoids for Tinnitus?

Project CBD

For the next couple days, she got extra sleep to aid recovery, and for good measure took an extra dose or two of CBD. Whatever the precise nature of the phantom sound, it often comes with a constellation of symptoms related to the disruption such a condition can bring: sleep problems, difficulty concentrating, low mood, etc.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What is CBN (Cannabinol)? How does the natural byproduct of THC work?

The Cannigma

Of course, this plant is now known to be marijuana (or Type I cannabis), which is still commonly used for sleep and analgesia today. In a 2019 animal study, CBN isolate was reported to relieve musculoskeletal pain. What can the current clinical trials tell us?

THC 140
article thumbnail

Cannabis 3.0 Accelerates Access to Consumer and Medical Research

Cannabis Law Report

Moreover over half of current cannabis users (52%) used apps on their mobile phone/tablet yesterday, with 66% reporting mobile app usage in the past week, and 74% reporting use in the past month, according to Vividata’s Spring Cannabis Consumer Study 2019. Virtual Clinical Trials transcend geographic, mobility and economic barriers.

article thumbnail

Getting to Know Cannabigerol with Bonni Goldstein, MD

Project CBD

And it does appear to address some of the main issues that people turn to cannabis for — inflammation, pain, anxiety, sleep problems, depression, and cancer. It was highly rated for anxiety, pain, depression, and sleep problems. But we may be on the cusp of having those trials, which would be very exciting.

article thumbnail

NORML 2019 Legislative Report

Cannabis Law Report

This report contains a detailed summary of 2019’s federal and state legislative victories.” 2019 has been an unprecedented year for the passage of state-level marijuana law reforms. “Never before in American history has marijuana policy advanced in Congress as far or as fast in one year as 2019.

article thumbnail

Medicinal cannabis users in the UK could be unfairly criminalised as study finds failures in roadside drug testing

Cannabis Law Report

The double-blind, randomised, placebo-controlled clinical trial took place over two years between 2017 and 2019 at the Center for Medicinal Cannabis Research at the University of California. As many patients use cannabis-based medicines to aid with sleep, the current detection window is of significant concern.